Activirosomes Limited

Pharmaceutical Manufacturing • Norwich, England, United Kingdom • 1-10 Employees

Company overview

Headquarters	Norwich, England, United Kingdom
Websites	activirosomes.com sedoparking.com
NAICS	3254
SIC	2834, 283
Keywords	Biotechnology, Vaccines, Immunology, Virology
Founded	2017
Employees	1-10
Socials

Key Contact at Activirosomes Limited

Amanda Mcmurray

CEO

About Activirosomes Limited

Activirosomes is developing new, inherently safe, low cost and easy to produce vaccine agents for prevention of viral infections. We use the "Active Virosome" technology platform, developed by co-founder Dr Vishwas Joshi of Seagull Biosolutions Pvt Ltd, www.seagullbiosolutions.in. It is a simple, safe and efficient biotechnology for producing candidate vaccines, and can be easily modified to produce vaccines for new viral infection outbreaks, simply by slotting in a suitable "cassette" of genetic information.

Activirosomes Limited revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$273,776
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Activirosomes Limited has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Activirosomes Limited has never raised funding before.

Frequently asked questions

Activirosomes Limited is located in Norwich, England, GB.

Activirosomes Limited was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Activirosomes Limited has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Activirosomes Limited

Amanda Mcmurray

CEO

4.8

40,000 users